Tempus AI (NASDAQ:TEM) Shares Up 5.4% – Time to Buy?

Shares of Tempus AI, Inc. (NASDAQ:TEM) rose 5.4% during trading on Friday . The stock traded as high as $36.20 and last traded at $36.10. Approximately 945,839 shares were traded during trading, a decline of 52% from the average daily volume of 1,990,661 shares. The stock had previously closed at $34.25.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TEM. Wolfe Research initiated coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Guggenheim initiated coverage on Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 target price for the company. Piper Sandler reaffirmed a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and increased their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Bank of America upped their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, Tempus AI has a consensus rating of “Moderate Buy” and an average target price of $56.00.

Tempus AI Stock Performance

The business has a 50-day moving average of $49.04 and a 200-day moving average of $46.62. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Insider Buying and Selling at Tempus AI

In other news, CFO James William Rogers sold 83,025 shares of the firm’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.30, for a total transaction of $3,511,957.50. Following the completion of the transaction, the chief financial officer now owns 231,280 shares of the company’s stock, valued at approximately $9,783,144. This trade represents a 26.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total value of $7,044,568.70. Following the transaction, the chief executive officer now directly owns 9,557,283 shares in the company, valued at $358,780,403.82. The trade was a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 845,041 shares of company stock valued at $35,125,473 in the last three months.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Franklin Resources Inc. increased its stake in shares of Tempus AI by 1.0% in the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after purchasing an additional 8,387 shares in the last quarter. Tidal Investments LLC purchased a new stake in shares of Tempus AI during the third quarter worth $7,633,000. Teachers Retirement System of The State of Kentucky grew its position in shares of Tempus AI by 6.3% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock valued at $7,160,000 after purchasing an additional 7,500 shares in the last quarter. Geode Capital Management LLC boosted its stake in Tempus AI by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares during the period. Finally, XTX Topco Ltd purchased a new stake in shares of Tempus AI during the 3rd quarter valued at $502,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.